Related Experiment Videos
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
1Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
Nature
|September 9, 1993
Summary
Botulinum neurotoxin A (BoNT/A) inhibits neurotransmitter release by cleaving the synaptic protein SNAP-25. This zinc-dependent protease activity targets a key component of synaptic vesicle exocytosis.
Area of Science:
- Neuroscience
- Molecular Biology
- Toxicology
Background:
- Clostridium botulinum produces toxins that block neurotransmitter release.
- Botulinum neurotoxin type B (BoNT/B) and tetanus toxin (TeTx) cleave synaptobrevin (VAMP).
Purpose of the Study:
- To investigate the mechanism of botulinum neurotoxin A (BoNT/A) in inhibiting neurotransmitter release.
- To identify the specific protein target of BoNT/A.
Main Methods:
- Proteolytic activity assay using isolated or recombinant BoNT/A L chain.
- Analysis of SNAP-25 cleavage in vitro.
- Investigation of BoNT/A catalytic activity dependence on divalent cations and specific residues.
Main Results:
- BoNT/A selectively proteolyzes the synaptic protein SNAP-25.
- Cleavage of SNAP-25 by BoNT/A occurs near the carboxyterminus.
- A glutamate residue in the BoNT/A L chain is essential for its zinc-dependent proteolytic activity.
Conclusions:
- BoNT/A functions as a zinc-dependent protease targeting SNAP-25.
- This action inhibits neurotransmitter release by affecting synaptic vesicle exocytosis.
- BoNT/A targets a distinct component of the synaptic fusion complex compared to BoNT/B and TeTx.